🇺🇸 OXY/APAP in United States

74 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 74

Most-reported reactions

1. Substance Use Disorder — 12 reports (16.22%)
2. Dependence — 11 reports (14.86%)
3. Overdose — 10 reports (13.51%)
4. Drug Dependence — 9 reports (12.16%)
5. Economic Problem — 8 reports (10.81%)
6. Death — 6 reports (8.11%)
7. Cardiac Arrest — 5 reports (6.76%)
8. Personal Relationship Issue — 5 reports (6.76%)
9. Anxiety — 4 reports (5.41%)
10. Completed Suicide — 4 reports (5.41%)

Source database →

Frequently asked questions

Is OXY/APAP approved in United States?

OXY/APAP does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for OXY/APAP in United States?

Purdue Pharma LP is the originator. The local marketing authorisation holder may differ — check the official source linked above.